Minerva Neurosciences (NERV) EPS (Basic) (2013 - 2026)
Minerva Neurosciences (NERV) posted EPS (Basic) of -$0.74 for Q1 2026, down 9.19% on a QoQ basis from -$0.67 in Q4 2025, and down 48.77% year-over-year from -$1.44 in Q1 2025.
Minerva Neurosciences (NERV) EPS (Basic) (2013 - 2026) Analysis & Trends
Minerva Neurosciences' EPS (Basic) history runs 14 years deep, the most recent figure standing at -$0.74 for Q1 2026.
- Quarterly EPS (Basic) fell 48.77% year-over-year to -$0.74 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.0 (up 58.0% YoY) and the FY2025 annual result came in at -$13.45, up 12.72% from the prior year.
- EPS (Basic) was -$0.74 for Q1 2026 at Minerva Neurosciences, down from -$0.67 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.36 in Q3 2025 and bottomed at -$17.77 in Q4 2022.
- A 5-year average of -$2.7 and a median of -$0.84 in 2024 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) tumbled 343.92% — and 2024, when it soared 96.41%.
- Minerva Neurosciences' EPS (Basic) stood at -$17.77 in 2022, then advanced by 10.31% to -$15.94 in 2023, then soared by 96.41% to -$0.57 in 2024, then declined by 17.87% to -$0.67 in 2025, then dropped by 9.19% to -$0.74 in 2026.
- Business Quant data shows NERV's EPS (Basic) at -$0.74 in Q1 2026, -$0.67 in Q4 2025, and -$0.36 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Minerva Neurosciences | 195.10 Mn | 195.10 Mn | - | -0.74 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.74 |
| Dec 31, 2025 | -0.67 |
| Sep 30, 2025 | -0.36 |
| Jun 30, 2025 | -0.43 |
| Mar 31, 2025 | -0.49 |
| Dec 31, 2024 | -0.57 |
| Sep 30, 2024 | -0.54 |
| Jun 30, 2024 | -0.78 |
| Mar 31, 2024 | -0.84 |
| Dec 31, 2023 | -15.94 |
| Sep 30, 2023 | -0.89 |
| Jun 30, 2023 | -1.12 |
| Mar 31, 2023 | -0.93 |
| Dec 31, 2022 | -17.77 |
| Sep 30, 2022 | -1.06 |
| Jun 30, 2022 | -1.29 |
| Mar 31, 2022 | -1.51 |
| Dec 31, 2021 | -4.00 |
| Sep 30, 2021 | -1.44 |
| Jun 30, 2021 | -1.68 |